Evidence suggesting that the expression of NEK7 and LHX9 may be potential reasons for the inverse correlation between Treg cells and CRC risks, whereas the factors for the anti-tumor effects of DN cells remains uncertain. The gene discussed is LHX9; the disease is colorectal carcinoma.